US 10080739
Aryl imidazoles and their use as anti-cancer agents
granted A61KA61K31/4178A61K31/4184
Quick answer
US patent 10080739 (Aryl imidazoles and their use as anti-cancer agents) held by APTOSE BIOSCIENCES INC. expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- APTOSE BIOSCIENCES INC.
- Grant date
- Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/4178, A61K31/4184, A61K31/4188, A61K31/4745